Ellis Owusu-Dabo

As Professor of Epidemiology and Global Health, his area of expertise is in Medical Epidemiology and applied public health technologies and is a former director of the Kumasi Centre for Collaborative Research. His research interest is in mainly non-communicable diseases in low-income country settings and also has considerable interest in population genomics of pulmonary tuberculosis. Ellis has secured and managed multimillion United States dollar research grants from principal granting institutions such as the European Union, National Institutes of Health, World Bank Group and the Bill & Melinda Gates Foundation as well as many bilateral organizations. He serves on several boards at both local and international levels. Owusu-Dabo has published over 200 research articles in peer-reviewed journals and is an international scholar at the Perelman School of Medicine at the University of Pennsylvania. He jointly developed patentable knowledge regarding the use of Granzyme B serum levels as biomarker to discriminate between sepsis and severe malaria (BNI009). He has been one of the leading voices on Ghana's Coronavirus fight in terms of advancing data-driven research on the subject. In September, 2022, he was re-elected as the Pro Vice-chancellor.

Owusu-Dabo has received awards from the Africa Network for Drug and Diagnostic Initiative (ANDI), KCCR, Seeding Labs/Novartis, Teaching and Learning Innovation Fund (World Bank Award) and a PhD Fellowship from Cancer Research UK. He was awarded the Africa Role Model in Academic Excellence Lifetime Achievement at the 13th Transform Africa Conference & Africa Role Model Awards in September 2022.